GUIDELINE FOR THE USE OF RED BLOOD CELL PRODUCTS BASED ON SCIENTIFIC EVIDENCE-Reference-Cited by-同舟云学术

GUIDELINE FOR THE USE OF RED BLOOD CELL PRODUCTS BASED ON SCIENTIFIC EVIDENCE

Published:2016 Issue:6 Volume:62 Page:641-650
ISSN:1881-3011
Container-title:Japanese Journal of Transfusion and Cell Therapy
language:en
Short-container-title:JJTC

Author:

Yonemura Yuji¹²,Matsumoto Masanori³²,Inada Eiichi⁴²,Ueda Yasunori⁵²,Ohishi Kohshi⁶²,Kino Shuichi⁷²,Kubo Takahiko⁸²,Kumakawa Midori⁹²,Sueoka Eizaburo¹⁰²,Sonoki Takashi¹¹²,Nagai Kazuhiro¹²²,Fujishima Naohito¹³²,Wakimoto Nobuhiro¹⁴²,Matsushita Tadashi¹⁵²

Affiliation:

1. Department of Transfusion Medicine and Cell Therapy, Kumamoto University Hospital

2. Guideline Committee of the Japan Society of Transfusion Medicine and Cell Therapy. Task Force Committee on the Guideline for the Use of Red Blood Cell Preparation

3. Department of Transfusion Medicine, Nara Medical University

4. Department of Anesthesiology and Pain Medicine, Juntendo University Faculty of Medicine

5. Department of Hematology, Kurashiki Central Hospital

6. Blood Transfusion Service, Mie University Hospital

7. Japanese Red Cross Hokkaido Block Blood Center

8. Shirota Obsterical and Gynecological Hospital

9. Department of Transfusion Medicine, Fukuoka University Hospital

10. Clinical Laboratory, Saga Medical University

11. Department of Hematology/Oncology and Department of Transfusion Medicine, Wakayama Medical University

12. Transfusion and Cell Therapy Unit, Nagasaki University Hospital

13. Division of Blood Transfusion, Akita University Hospital

14. Department of Orthopedic Surgery, Teikyo University School of Medicine

15. Department of Transfusion Service, Nagoya University Hospital

Publisher

Japan Society of Transfusion Medicine and Cell Therapy

Subject

Computer Networks and Communications,Hardware and Architecture,Software

Link

https://www.jstage.jst.go.jp/article/jjtc/62/6/62_641/_pdf

Reference47 articles.

1. 1) 福井次矢, 山口直人: Minds診療ガイドライン作成の手引き2014, 医学書院, 2014.

2. 2) 「難治性貧血の診療ガイド」編集委員会: 難治性貧血の診療ガイド～特発性造血障害の病態・診断・治療の最新動向, 南江堂, 2011.

3. 3) Simon TL, Alverson DC, AuBuchon J, et al: Practice parameter for the use of red blood cell transfusions: Developed by the Red Blood Cell Administration Practice Guideline Development Task Force of the College of American Pathologists. Arch Pathol Lab Med, 122: 130-138, 1998.

4. 4) Murphy MF, Wallington TB, Kelsey P, et al: Guidelines for the clinical use of red cell transfusions. Brit J Haematol, 113: 24-31, 2001.

5. 5) 研究代表者: 小澤敬也: 厚生労働科学研究費補助金難治性疾患克服研究事業特発性造血障害に関する調査研究 (平成20年度) 輸血後鉄過剰症の診療ガイド, 2008.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ferric derisomaltose for the treatment of iron deficiency anemia with postpartum hemorrhage: Results of a single‐arm, open‐label, phase 3 study in Japan;Journal of Obstetrics and Gynaecology Research;2023-01-18

2. Effects of red blood cell concentrate transfusion on blood tacrolimus concentration;International Journal of Clinical Pharmacy;2020-04-28